ArticleNature cancer2024

Integrative proteogenomic profiling of high-risk prostate cancer samples from Chinese patients indicates metabolic vulnerabilities and diagnostic biomarkers.

Baijun Dong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.